Pharmacy Times September 12, 2024
Fred Barton discusses the role of PBMs in making prescription drug decisions.
In an interview with Pharmacy Times® at the Community Oncology Alliance (COA) 2024 Payer Exchange, Fred Barton, PharmD, and vice president of clinical product and partnerships at AffirmedRx, explains the challenges of PBMs in the health care industry and the steps that need to be taken to promote more transparency.
Pharmacy Times: What factors regarding the role of PBMs were most significant in your session?
Fred Barton: Yeah, we discussed a lot today, obviously, about transparency. It’s the big kind of thing in the space. But really, what does transparency mean? What can transparency change when it comes to PBM and then also some of the factors around,...
Today's Sponsors
Today's Sponsor